For in situ hybridization (ISH), development of sensitive, nontoxic alternatives to the use of radioactivity is a constant concern. In this trend, and dose to chromogenes and fluorophores, chemiluminescence appears an attractive method. A first positive experience in immunocytochemistry and in ISH, by using the enhanced luminol as luminogene substrate for horseradish peroxidase (HRF') led us to compare the sensitivity of 35S autoradiography and chemiluminescence. For this purpose, we used three human carcinoma cell lines, CaSki [400-600 copies of human papilloma virus (HW) 161, HeLa (10-50 copies of HPV lS), and SiHa (1-5 copies of HPV 16), and 40 biopsy specimens of human cervical preneoplastic and neoplastic lesions. We performed ISH by using HPV cDNA biotin-labeled probes, detected by a two-step immunocytochemical reaction, the secondary antibodies being either 35S-labeled for autoradiography or HRFlabeled for 1996) 
Introduction
Since the introduction of in situ hybridization (ISH), described by Pardue and Gall (38) at the end of the 1960s, radioactive detection of nucleic acids remains the reference technique (6, 52, 53) . Although radioactive ISH is a highly sensitive method, the use of radioisotopes is associated with difficulties (short half-life and poor resolution for 32P-and 35S-, and long exposure time for 3H-labeled probes) (5,6) which limit routine clinical application (20, 24, 45) . Moreover, radioactivity requires special handling, increasing the cost of this detection method.
These drawbacks have stimulated the development of nonradioactive methods. Since the first description of a biotin-labeled chemiluminescence. An intensified CCD camera allowed acquisition of the luminescent signal. After only 10 min of photon accumulation, on cell line smears as well as on serial tissue sections, chemiluminescence gave comparable results to those obtained by a 3-week exposure for 35S autoradiography. A quantitative approach on cervical biopsy specimens confirmed this similar level of sensitivity by measuring the area of S5S-or chemiluminescence-stained nudei. Our results indicate that chemiluminescence is a credible and perfectible alternative to radioisotopes for in situ detection of nucleic acids by hybridization. (J Histochem Cytochem nucleotide (28), several nonradioactive methods have been described (13.25 ; for reviews see 23.26). Commonly, these detection systems are based on biotin-, digoxigenin-, or fluorescein-labeled oligonucleotides, cDNAs, or riboprobes, detected either via enzymeor fluorochrome-conjugated reporter molecules (5,53). Despite their innocuousness, low cost, and easier handling, storage, and disposal, the sensitivity of nonradioactive methods remains debatable (5J1, 12,36,44,47,50,52) . Because of their high sensitivity, which is equal or superior to radioisotopes, bioluminescence and chemiluminescence detection systems have already gained wide application in immunoassays, molecular biology, and studies of reporter genes (1, (7) (8) (9) 21, 26, 34, 39, 41, 48) .
Since the first description of in situ chemiluminescence by Hawkins and Cumming in 1990 (16) , the feasibility and high sensitivity (compared to colorimetric detection) of in situ chemiluminescence have been demonstrated for immunocytochemistry and in situ hybridization (30, 35, 40) . These results led us to evaluate the ability of in situ chemiluminescence to detect human papilloma virus (HPV) infection on cervical biopsy specimens, using autohistoradiography as a reference.
Forty cervical lesions (ranging from dysplasia to in situ carcinoma) were selected. To achieve a strict comparison of the two detection systems. we used HPV biotinylated probes detected in a secondary reaction by the same immunological construction labeled with either an enzyme or an isotope. The enhanced luminol peroxidase system, the most widely used for in situ chemiluminescent detection (27) . and 3%labeled antibodies, providing the best compromise between resolution and exposure time for in situ autoradiography (51-53). were selected.
This report shows that enhanced chemiluminescence (ECL) detects HPV genomes in situ with similar resolution and equal sensitivity compared to those of radioactive techniques, but with an important gain in result acquisition times: a few minutes vs several days.
Materials and Methods
Instrumentation and Luminescent Signal Detection. The luminescent signal was detected by a photon-collecting device. This equipment (Figure 1) consisted of an Olympus BH2 light microscope connected to a intensified CCD (charge-coupled device) camera (C2400-47; Hamamatsu Photonics. Hamamatsu, Japan) (spectral response 280-650 nm. sensitive range 10"-10-" lux. horizontal center resolution 300 TV line). To avoid contamination by external light. the detection system was enclosed in a light-tight cabinet. The chemiluminescent signal was visualized on a color video monitor. An ARGUS 50 image processor (Hamamatsu) allowed signal processing and analysis. First. an image of tissue sections or cell smears in transmitted light was acquired. In a second step. by using a photon-counting function allowing photon accumulation lasting from 1 sec to several minutes, an image of the luminescent signal emitted by the cellular preparation was acquired on the monitor screen. The software allowed superimposition of the chemiluminescent image on the conventional transmitted light image.
Negative controls produced discrete luminous signals of homogeneous density on the video monitor, providing the background threshold level obtained in a pixel-bypixel procedure. The background subtraction was possible after image acquisition. The images shown were obtained by photographing the screen.
Preparation of Cell Smears and Tissue. Three carcinoma cell lines (American Tissue Type Collection; Rockville. MD) were used: CaSki containing 400-600 copies of HPV 16. HeLa containing 10-50 copies of HPV 18. and SiHa containing 1-3 copies of HPV 16. Cells were grown to confluence in Dulbecco's modified Eagle's medium with 10% fetal calf serum. After mechanical detachment and washing. cells were resuspended in fresh culture medium before cytocentrifugation on amino-propyl-triethoxysilane (APES)coated slides. Air-dried smears were fixed in acetone at -2O'C. The cytological preparations were stored with a desiccant for several weeks at -20°C.
Forty formalin-fixed. paraffin-embedded biopsy specimens or samples from surgical specimens of human cervix were used. The cervical specimens obtained included both benign condyloma and in situ carcinoma (see Table 1 ).
The tissues were selected according to their HPV infection status and were classified into two groups. The first group comprised 20 lesions positive on routine in situ hybridization for HPV 16/18. The second group comprised 20casesassigned as negative for HPV 16/18 aswell as HPV 31/33/51 and HPV 611 1. Briefly, routine in situ hybridization was performed according to the protocol of a commercial kit (Enzo Diagnostics; New York, NY). We modified only the colorimetric detection, using diaminobenzidine (DAB) instead of amino-ethyl carbazol (AEC) as chromogenic peroxidase substrate.
Serial sections of 6 pm were collected on APES-coated slides and dried overnight at 56'C. After rehydration, the tissue sections were ready for the hybridization step.
In Sicu Hybridization. On tissue sections. a 15-min proteinase K (0.25 mglml) (Sigma; Sr Louis, MO) pretreatment was applied. In a second step. digested sections or smears were overlaid with 20 pl of hybridization mix [SO% formamide. 2 x saline sodium citrate (SSC). 10% dextran sulfate. 0.025% herring sperm DNA] containing 0.5 pg/ml of HPV 16118. HPV 31/33/51, or HPV 6\11 biotinylared cDNA probes (Enzo Diagnostics) and coverslipped. Simultaneous denaturation was carried out at 96°C for 10 min. Slides were incubated at 42°C for 18 hr in a moist chamber. After hybridization. coverslips were removed and slides were washed in 40% forma- 
Score of HPV-positive cases detectedby colorimetric, radioisotopic, or chemiluminescent in situ hybridization on condylamata and cervical intraneoplastic (CIN) lesionsa
In group A. whatever the detection method. all cases were positive. In 20 cases scored as negative with diaminobenzidine (DAB)/peroxidase (group B). six were found to be positive with 3% and enhanced chemiluminescence (ECL).
mide, 2 x SSC for 15 min at 42'C, followed by three rinses in SSC solutions of increasing stringency (2 x SSC, 1 x SSC. 0.5 x SSC) for 5 min each at room temperature (RT). Samples were then rinsed in PBS, pH 7.4.
for 5 min. After endogenous peroxidase inhibition (HzOz 0.3%. sodium azide 0.1% in PBS for 10 min), smears and tissue sections were placed into 5 % skimmed milk in PBS for 15 min to block nonspecific binding and were incubated for 30 min at RT with a monoclonal mouse-biotin antibody 1:200 (164 kg/ml; Dakopatts, Glostrup, Denmark). After two washes in PBS, the nonspecific immunoglobulin binding was inhibited by a 5-min saturation in 5% skimmed milk. To achieve a relatively strict evaluation of chemiluminescence and autoradiography, the sections were incubated for 1 hr in peroxidase-or 35S (specific activity 744 Ci/mmol)-conjugated goat anti-mouse immunoglobulins (Jackson, West Grove. PA and Amersham, Amersham, UK). The immunoglobulin concentrations used were respectively 0.002 mglml for the enyzme-linked antibodies and 0.004 mg/ml (2 pCi/ml) for the radiolabeled antibodies. After three washes in PBS, pH 8.6, the specimens were ready for chemiluminescent or autoradiographic detection. Before chemiluminescent analysis, the slides can be dried and stored at -7O'C without any significant loss of light signal.
Negative Control. For HPV 16/18 routine positive cases and carcinoma cell lines, an HPV 6/11 biotinylated cDNA probe (Enzo Diagnostics) was used as negative control at the same DNA concentration as Type HPV 16/18. Chemiluminescent Detection. After a 2-min preincubation with a freshly prepared solution (v/v) of enhanced chemiluminescent reagent (ECL, luminol + enhancer; Amersham), the tissue sections and cell smears were simply coverslipped and observed with a microscope equipped with an ICCD camera. A photon accumulation time of 10 min was applied in each case. If necessary, the slides could be immediately redipped and reanalyzed.
For delayed reexamination, after three washes in PBS, pH 7.4, the slides were dried and stored at -70°C for up to 1 month. Autoradiographic Detection. After the last wash in PBS, pH 8.6, following the incubation with the secondary antibody labeled with j5S, the slides were dehydrated, dried for 5 min at 3 7 T , and then subbed in a Kodak NTB 2 autoradiographic emulsion. After drying, the emulsion was exposed in light-tight boxes at 4'C for 3 weeks. The emulsion was developed with Dektol and Unifix at 16°C according to a Kodak protocol.
The sections and cell smears were observed without counterstaining by light-and darkfield microscopy.
Quantitative Analysis. Eight cases positive by chemiluminescence and autoradiography for HPV 16/18 infection were analyzed. The positively labeled nuclear area was quantified by using image analysis software (ARGUS 50; Hamamatsu). After thresholding of the specific isotopic or luminescent signal based on the relevant negative control (see above), the positive signal was imaged (see Figure 4 ) and the labeled area was calculated (Gble 2).
Results

Carcinoma Cell Lines
The figures show that the HPV genomes were clearly detected with chemiluminescence and autoradiography in Caski (400-600 copies HPV 16) and HeLa cells (10-50 copies HPV 18) ( Figure 2 ). In this carcinoma cell line, the resolution and intensity provided by both signals were similar. The luminescent and isotopic signals were well limited to cell nuclei. On HeLa cells, the isotopic signal (Figure 2b) was slightly weaker than that from chemiluminescence (Figure 2d) .
On SiHa cells, both methods, cDNA biotinylated probes localized by antibodies coupled to either 3% or to HRP, failed in our hands to detect the 1-5 copies of HPV 16 contained in the nucleus of this carcinoma cell line.
Cervical Biopsy Specimens
On the 20 HPV 16118-infected biopsy specimens used in a first step as positive control, autoradiography and chemiluminescence gave results identical to those obtained by colorimetric DAB peroxidase reaction. As we have noted previously (30), the chromogenic reaction provided better resolution than luminescence and autoradiography ( Figure 3 ). However, chemiluminescence gave a signal definition slightly sharper than that of isotopic detection (Figure 3 ). On serial sections of many cases, we observed that chemiluminescence and autoradiography identified more infected Table 2 (Figure 3) than were detected on the chromogenic DABlabeled slide. These infected nuclei were recruited among the upper middle of the stratified squamous epithelium nuclei. In the second group of patients. consisting of cases negative for HPV by routine detection, luminol-amplified chemiluminescence and radioactivity increased detection sensitivity. In fact. these two tracers allowed detection of HPV in six cervical specimens previously scored as negative (Table 1) .
. Quantification in arbitrary units of the positively /abe/ed areas (HPV-injicted nuclei) in eifht human cervical lesions
To define more precisely the level of sensitivity of each of the tracers, chemiluminescence vs radioactivity. we made a quantitative analysis of the specifically labeled surface ( Table 2) . This analysis, carried out with the same software on serial sections from 10 cases, showed that the staining surface could be considered equivalent to either isotopic or chemiluminescent labeling.
Discussion
The prcscnt study compared the sensitivity of radioactivity and chemiluminescence for in situ detection of HPV genomes. This virus infection model is generally used in studies comparing ISH techniques for sensitivity (17,36.44.50) because it is available in the form of three cell lines containing a known number of viral genome copies Although a number of studies have reported a sensitivity for chemiluminescence cquivalcnt to or superior to that of radioactivity in solution immunoassays and antigen detection on membranes (2.4.14.15.33) . this is the first evaluation showing that chemiluminescence sensitivity is equivalent to that given by "S autoradiography for in situ detection of nucleic acids. We were able to demonstrate that signal resolution was also comparable to that provided by "S but. in contrast to autoradiography, the definition of the chemiluminescence image can be improved. Moreover. the immediate availability of chemiluminescence results is a highly valuable advantage.
Because enzymatic incorporation of differently labeled nuclcotides with radioisotopes or haptens is known to influence hybridization (22.50). we chosc biorinylatcd probes that were detected, in a second immunocytochemical step. with either "Sor peroxidase-labeled antibodies. In this way, sensitivity depended solcly on the tracer.
Despite its limited amplification, the immunocytochemical method allowed the detection of HPV 18 genomes in HcLa cells with the utilization of widely available probes and without particular refinements to the hybridization technique (36.50). However. the 1-5 viral copies present in SiHa cells were undetectable under ourconditions. although such a lcvcl ofsensitivity has been reported for chromogenic (17.50) and fluorescent (44) labeling. However. these studies uscd detection based on streptavidin systems and oligonucleotide probes, rcspectivcly.
In the uterine cervix cancer cell lines we uscd. the location of the viral genome is nuclear and labels with a dotted appearance (1;.18.29,36.46,50) . Autoradiographic and chemiluminescent labelings were limited to the nuclear area but were more diffuse. This loss of resolution. compared to colorimetric and fluorescent tracers, is currently described for autoradiography (19.43.49) . For chcmiluminescence, lack of definition can be explained by the diffusion of lumincscent reaction product (27). Another explanation may be the high sensitivity of the signal detection. Indeed. Siadat-Pajouh et al. (44) recently showed. using an oligonucleotide probe and fluorescence amplification for enhanced sensitivity. that the papilloma virus labeling in CaSki cell nuclei appeared diffuse. analogous to the pattern of the chemiluminescent signal we obtained. We also tested the efficiency of chemiluminescent detection of papilloma virus on preneoplastic and neoplastic lesions of the human uterine cervix. Compared to routine chromogenic detection, chemiluminescence allowed identification of a greater number of viral infestations in patients previously considered as "uninfected," i.e., in our series, six cases were revealed as positive from within the negative patient group. In terms of sensitivity and signal definition, chemiluminescence appeared equivalent to 3sS. The main advantage of the chemiluminescent detection is the rapidity of acquisition of the results, available only a few hours after the last stringent slide wash as opposed to the several weeks needed for emulsion exposure to radioactivity. Moreover, chemiluminescence has the advantages proper to a nonisotopic tracer (low reagent cost, long half-life, lack of personal and environmental hazards) that allow its use in many laboratories.
With the trend towards constantly increasing sensitivity in nonisotopic ISH techniques (chromogenic, fluorescence, timeresolved fluorescence, colloidal gold), with or without preliminary amplification through the polymerase chain reaction (10,32,36,  37.54) . the sensitivity of chemiluminescence makes this approach a serious alternative to radioactive localization of nucleic acids and antigens present in small amounts within cells. However, chemiluminescence must be compared with other luminescent systems, such as fluorescence and colloidal gold observed in reflection microscopy. However, unlike colloidal gold, which has already been used with success for sensitive localization of mRNAs, fluorescence appears mainly restricted to cytogenetic analysis on interphasic or metaphasic chromosomes.
Today, wide-scale utilization of chemiluminescence is restricted by the need for expensive specific equipment (the cost of an ICCD camera is around $40,000) and incomplete signal resolution. However, this latter drawback may not preclude the development of chemiluminescence for research or diagnostic applications when precise subcellular information is not required. Moreover, we can hope that the problem of chemiluminescent signal resolution will be solved by improving current detection technology. intensity may be increased. a n d t h e half-life of t h e product emitting light reduced, with t h e use of more suitable substrates or enzymes. Second, improvements in camera components (image intensifier and CCDs) are expected from astrophysics technology.
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